302800-13-1

Basic information

• Product Name: (5-Bromo-2-nitro-phenyl)-methyl-amine
• Synonyms: (5-Bromo-2-nitro-phenyl)-methyl-amine;BENZENAMINE, 5-BROMO-N-METHYL-2-NITRO-;5-broMo-N-Methyl-2-nitrobenzenaMine;BenzenaMine, 5-broMo-N-Me...;5-broMo-N-Methyl-2-nitroaniline;4-Bromo-2-methylamino-1-nitrobenzene
• CAS NO: 302800-13-1
• Molecular Formula: C₇H₇BrN₂O₂
• Molecular Weight: 231.04668
• Mol File: 302800-13-1.mol
• Article Data: 46

Chemical Properties

• Boiling Point: 327.509 °C at 760 mmHg
• Flash Point: 151.872 °C
• Appearance: /
• Density: 1.687
• Storage Temp.: 2-8°C(protect from light)
• PKA: -1.33±0.25(Predicted)
• CAS DataBase Reference: (5-Bromo-2-nitro-phenyl)-methyl-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (5-Bromo-2-nitro-phenyl)-methyl-amine(302800-13-1)
• EPA Substance Registry System: (5-Bromo-2-nitro-phenyl)-methyl-amine(302800-13-1)

Safety Data

• Hazardous Substances Data: 302800-13-1(Hazardous Substances Data)

Usage

General Description

(5-Bromo-2-nitro-phenyl)-methyl-amine, also known as BMMA, is an organic compound with the molecular formula C7H7BrN2O2. It is a yellow solid that is primarily used as a chemical intermediate in the synthesis of pharmaceuticals and other organic compounds. BMMA contains a nitro group, a bromine atom, and a phenyl ring, making it a versatile building block for organic synthesis. It has been used in the development of various pharmaceuticals and agrochemicals due to its ability to readily undergo chemical reactions and form a wide variety of derivatives. Its chemical structure and properties make it a valuable tool for the synthesis of complex organic compounds.

Upstream product

• 5228-61-5 5-bromo-2-nitroaniline 
• 74-88-4 methyl iodide 
• 321-23-3 4-bromo-2-fluoronitrobenzene 
• 593-51-1 methylamine hydrochloride 
• 51686-78-3 2,4-dibromonitrobenzene 
• 860557-59-1 (3-chloro-4-nitro-phenyl)-arsonic acid 
• 74-89-5 methylamine 
• 610-38-8 4-bromo-1,2-dinitrobenzene 

Downstream Products

• 958859-48-8 6-bromo-1-methyl-2-(((1S,5R,6R)-6-(phenoxymethyl)-3-aza-bicyclo[3.1.0]hexan-5-yl)methyl)-1H-benzo[d]imidazole 

Relevant articles and documents

THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Provided herein are compounds, preferably thyroid hormone receptor beta (THR beta) agonist compounds, compositions thereof, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta.

BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF

The present disclosure provides bifunctional compounds as IRAK4 degraders via ubiquitin proteasome pathway, and method for treating diseases modulated by IRAK4.

Cu-Catalyzed C-H Allylation of Benzimidazoles with Allenes

CuH-catalyzed intramolecular cyclization and intermolecular allylation of benzimidazoles with allenes have been described. The reaction proceeded smoothly with the catalytic system of Cu(OAc)2/Xantphos and catalytic amount of (MeO)2MeSiH. This protocol features mild reaction conditions and a good tolerance of substrates bearing electron-withdrawing, electron-donating, or electron-neutral groups. A new catalytic mechanism was proposed for this copper hydride catalytic system.